Detailed Information on Publication Record
2018
Ultra-sensitive detection of tyrosine kinase inhibitor resistant mutations in chronic myeloid leukemia patients using Miseq Illumina next generation sequencing platform
ROMŽOVÁ, Marianna, Dagmar SMITALOVÁ, Nikola TOM, Tomáš JURČEK, Jiří MAYER et. al.Basic information
Original name
Ultra-sensitive detection of tyrosine kinase inhibitor resistant mutations in chronic myeloid leukemia patients using Miseq Illumina next generation sequencing platform
Authors
ROMŽOVÁ, Marianna (703 Slovakia, guarantor, belonging to the institution), Dagmar SMITALOVÁ (203 Czech Republic, belonging to the institution), Nikola TOM (203 Czech Republic, belonging to the institution), Tomáš JURČEK (203 Czech Republic, belonging to the institution), Jiří MAYER (203 Czech Republic, belonging to the institution) and Zdeněk RÁČIL (203 Czech Republic, belonging to the institution)
Edition
23rd Congress of the European Hematology Association, Stockholm, Sweden in HemaSphere, 2018
Other information
Language
English
Type of outcome
Konferenční abstrakt
Field of Study
10606 Microbiology
Confidentiality degree
není předmětem státního či obchodního tajemství
RIV identification code
RIV/00216224:14740/18:00106186
Organization unit
Central European Institute of Technology
Keywords in English
CML; NGS; detection; Illumina
Tags
Změněno: 26/3/2019 12:48, Mgr. Pavla Foltynová, Ph.D.
Abstract
V originále
Ultra-sensitive detection of tyrosine kinase inhibitor resistant mutations in chronic myeloid leukemia patients using Miseq Illumina next generation sequencing platform, Ultra-sensitive detection of tyrosine kinase inhibitor resistant mutations in chronic myeloid leukemia patients using Miseq Illumina next generation sequencing platform.
Links
| NV17-30397A, research and development project |
|